World Courier making multi-million dollar tech investment

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/ake1150sbe)
(Image: Getty/ake1150sbe)

Related tags: Logistics, Pharmaceutical companies, Technology, Supply chain, Cell therapy

World Courier has made a multimillion-dollar investment in its supply chain technology to help meet the expanding needs of the pharmaceutical industry.

World Courier opened new offices worldwide in 2018, and unveiled personalized supply chain​ teams to support direct-to-patient​, cell and gene therapy, and clinical trial execution​.

The company began investing in technology solutions and infrastructure in 2015 and has since implemented upgrades in Canada, Portugal, and Japan. Improvements following the most recent investment are set to reach additional markets in 2019.

Sam Herbert, president of World Courier told us, “As technology continues to drive innovation in pharmaceutical care, we must also use it to progress the leading edge of logistics and commercialization platforms. We recognized the opportunity to evolve our solutions even further and provide customers, particularly those introducing highly specialized therapies, greater value.”

This technology “transformation”​ includes real-time temperature and GPS tracking, and will support system integration and enhance order entry functionality for customers.

“In addition, we will now have the ability to further integrate and enable reliable coordination between customers, airlines, and regulatory agencies, all of whom need to be in lock-step as products make their way from manufacturers to patients,” ​said Herbert.

As the pharmaceutical and biomedical industries evolve, our partners expect World Courier to continue to lead the industry in specialty logistics best practices,”​ he said, adding that the company is focusing on proving logistics and efficiency throughout the supply chain by expanding its ability to support partners in additional markets.

Investment details have not been disclosed at this time. 

Related news

Related products

show more

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us

Featured Events

View more


View more